Oncolytic virotherapy with modified adenoviruses and novel therapeutic targets
Author:
Publisher
Informa Healthcare
Subject
Clinical Biochemistry,Drug Discovery,Pharmacology,Molecular Medicine
Link
http://www.tandfonline.com/doi/pdf/10.1517/14728222.2012.712962
Reference126 articles.
1. Recent progress in the battle between oncolytic viruses and tumours
2. Clinical trial results with oncolytic virotherapy: a century of promise, a decade of progress
3. The RB and p53 pathways in cancer
4. An Adenovirus Mutant That Replicates Selectively in p53- Deficient Human Tumor Cells
5. Mechanisms of apoptosis regulation by viral oncogenes in infection and tumorigenesis
Cited by 28 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Global prevalence of pre-existing antibodies against human adenoviruses, surveyed from 1962-2021;Intervirology;2024-03-08
2. Inhibition of human adenovirus replication by TRIM35-mediated degradation of E1A;Journal of Virology;2023-08-31
3. Oncolytic virotherapy using neural stem cells as a novel treatment option for glioblastoma multiforme;MedComm – Oncology;2023-01-31
4. Cross Talk of Macrophages with Tumor Microenvironment Cells and Modulation of Macrophages in Cancer by Virotherapy;Biomedicines;2021-09-24
5. Combinatorial Approaches for Cancer Treatment Using Oncolytic Viruses: Projecting the Perspectives through Clinical Trials Outcomes;Viruses;2021-06-29
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3